{"id":12452,"date":"2025-07-30T17:48:32","date_gmt":"2025-07-30T15:48:32","guid":{"rendered":"https:\/\/www.kliinikum.ee\/yhendlabor\/?page_id=12452"},"modified":"2025-12-11T17:12:58","modified_gmt":"2025-12-11T15:12:58","slug":"aripiprasool-ja-dehudroaripiprasool-p-aripiprasoledehydroaripiprazole","status":"publish","type":"page","link":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/ravimiseire-uuringud\/aripiprasool-ja-dehudroaripiprasool-p-aripiprasoledehydroaripiprazole\/","title":{"rendered":"Aripiprasool ja deh\u00fcdroaripiprasool (P-Aripiprasole+dehydroaripiprazole)"},"content":{"rendered":"\n<p><em>Kliinilise keemia ja laboratoorse hematoloogia osakond<\/em><\/p>\n\n\n\n<p><strong>Aripiprasool <\/strong>kuulub at\u00fc\u00fcpiliste e teise p\u00f5lvkonna antips\u00fchhootiliste ravimite r\u00fchma, mida kasutatakse skisofreenia ja I t\u00fc\u00fcpi bipolaarse meeleoluh\u00e4ire ravis t\u00e4iskasvanutel ning lastel. Aripiprasooli manustatakse suukaudselt ning see imendub h\u00e4sti, saavutades maksimaalse plasmakontsentratsiooni 3\u20135 tunni jooksul peale manustamist. Veres transporditakse aripiprasooli peamiselt albumiiniga seotult.<\/p>\n\n\n\n<p>Ravimi metabolism toimub maksas, kus tekib ka aktiivne metaboliit deh\u00fcdroaripiprasool, mis moodustab umbes 40% aripiprasooli kontsentratsioonist. Eliminatsiooni poolv\u00e4\u00e4rtusaeg on 75\u2013146 tundi, eritumine toimub uriini ja v\u00e4ljaheidetega.<\/p>\n\n\n\n<p>K\u00f5ige sagedamini kirjeldatud k\u00f5rvaltoimeteks on akatiisia (f\u00fc\u00fcsiline paigalp\u00fcsimatus, ps\u00fc\u00fchiline rahutus) ja iiveldus. \u00dcleannustamisel v\u00f5ivad tekkida letargia, verer\u00f5hu t\u00f5us, unisus, tahh\u00fckardia, iiveldus, oksendamine ja k\u00f5hulahtisus.<\/p>\n\n\n\n<p class=\"has-medium-font-size\"><strong>Uuritav materjal, selle v\u00f5tmine, saatmine ja s\u00e4ilitamine<\/strong><\/p>\n\n\n\n<p>Proov tuleb v\u00f5tta vahetult enne j\u00e4rgmise ravimiannuse manustamist!<\/p>\n\n\n\n<figure class=\"wp-block-table is-style-stripes\"><table width=\"100%\"><tbody><tr><td width=\"1%\"><\/td><td width=\"15%\"><strong>Katsuti<\/strong><\/td><td width=\"84%\">K2E\/K3E-katsuti (lilla kork)<\/td><\/tr><tr><td><\/td><td><strong>S\u00e4ilivus<\/strong><\/td><td>plasmas +4 \u00b0C \u00fcks n\u00e4dal<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"has-medium-font-size\"><strong>Anal\u00fc\u00fcsi tegemise aeg<\/strong><strong>:<\/strong> \u00fcks kord n\u00e4dalas<\/p>\n\n\n\n<p class=\"has-medium-font-size\"><strong>Anal\u00fc\u00fcsimeetod<\/strong><strong>:<\/strong> vedelikkromatograafia-massispektromeetria (LC-MS\/MS)<\/p>\n\n\n\n<p class=\"has-medium-font-size\"><strong>Referentsv\u00e4\u00e4rtused<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-table\"><table width=\"100%\"><tbody><tr><td width=\"1%\"><\/td><td width=\"69%\"><strong>Soovituslik terapeutiline vahemik* <br><\/strong>(aripiprasool + deh\u00fcdroaripiprasool)<\/td><td width=\"30%\">150\u2013500 \u00b5g\/L<\/td><\/tr><tr><td><\/td><td><strong>Toksiline kontsentratsioon*<\/strong><\/td><td>&gt;1000 \u00b5g\/L<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p>* C. Hiemke et al (2018). \u201eConsensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017\u201c Pharmacopsychiatry 2018; 51: 9\u201362<\/p>\n\n\n\n<p>Terapeutiline vahemik ja toksiline piir ei ole \u00fcheselt m\u00e4\u00e4ratud. Antud terapeutiline vahemik p\u00f5hineb populatsiooniuuringutel, seega ei pruugi olla rakendatav igale patsiendile. M\u00f5ne patsiendi puhul v\u00f5ib optimaalne ravivastus olla ravimikontsentratsiooni juures, mis j\u00e4\u00e4b antud vahemikust v\u00e4lja.<\/p>\n\n\n\n<p class=\"has-medium-font-size\"><strong>N\u00e4idustus ja kliiniline t\u00e4hendus<\/strong><\/p>\n\n\n\n<p>Ravi j\u00e4lgimine, optimaalse raviskeemi leidmine ja kontroll, ravimim\u00fcrgistuse diagnostika.<\/p>\n\n\n\n<p>Koostajad: Julia Keller, Jelena Beljantseva<br>03.06.2020<\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Kliinilise keemia ja laboratoorse hematoloogia osakond Aripiprasool kuulub at\u00fc\u00fcpiliste e teise p\u00f5lvkonna antips\u00fchhootiliste ravimite r\u00fchma, mida kasutatakse skisofreenia ja I t\u00fc\u00fcpi bipolaarse meeleoluh\u00e4ire ravis t\u00e4iskasvanutel ning lastel. Aripiprasooli manustatakse suukaudselt ning see imendub h\u00e4sti, saavutades maksimaalse plasmakontsentratsiooni 3\u20135 tunni jooksul peale manustamist. Veres transporditakse aripiprasooli peamiselt albumiiniga seotult. Ravimi metabolism toimub maksas, kus tekib ka [&hellip;]<\/p>\n","protected":false},"author":38,"featured_media":0,"parent":7301,"menu_order":3,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_uag_custom_page_level_css":"","footnotes":""},"class_list":["post-12452","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aripiprasool ja deh\u00fcdroaripiprasool (P-Aripiprasole+dehydroaripiprazole) - \u00dchendlabor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/ravimiseire-uuringud\/aripiprasool-ja-dehudroaripiprasool-p-aripiprasoledehydroaripiprazole\/\" \/>\n<meta property=\"og:locale\" content=\"et_EE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aripiprasool ja deh\u00fcdroaripiprasool (P-Aripiprasole+dehydroaripiprazole) - \u00dchendlabor\" \/>\n<meta property=\"og:description\" content=\"Kliinilise keemia ja laboratoorse hematoloogia osakond Aripiprasool kuulub at\u00fc\u00fcpiliste e teise p\u00f5lvkonna antips\u00fchhootiliste ravimite r\u00fchma, mida kasutatakse skisofreenia ja I t\u00fc\u00fcpi bipolaarse meeleoluh\u00e4ire ravis t\u00e4iskasvanutel ning lastel. Aripiprasooli manustatakse suukaudselt ning see imendub h\u00e4sti, saavutades maksimaalse plasmakontsentratsiooni 3\u20135 tunni jooksul peale manustamist. Veres transporditakse aripiprasooli peamiselt albumiiniga seotult. Ravimi metabolism toimub maksas, kus tekib ka [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/ravimiseire-uuringud\/aripiprasool-ja-dehudroaripiprasool-p-aripiprasoledehydroaripiprazole\/\" \/>\n<meta property=\"og:site_name\" content=\"\u00dchendlabor\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-11T15:12:58+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutit\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/ravimiseire-uuringud\\\/aripiprasool-ja-dehudroaripiprasool-p-aripiprasoledehydroaripiprazole\\\/\",\"url\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/ravimiseire-uuringud\\\/aripiprasool-ja-dehudroaripiprasool-p-aripiprasoledehydroaripiprazole\\\/\",\"name\":\"Aripiprasool ja deh\u00fcdroaripiprasool (P-Aripiprasole+dehydroaripiprazole) - \u00dchendlabor\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/#website\"},\"datePublished\":\"2025-07-30T15:48:32+00:00\",\"dateModified\":\"2025-12-11T15:12:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/ravimiseire-uuringud\\\/aripiprasool-ja-dehudroaripiprasool-p-aripiprasoledehydroaripiprazole\\\/#breadcrumb\"},\"inLanguage\":\"et\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/ravimiseire-uuringud\\\/aripiprasool-ja-dehudroaripiprasool-p-aripiprasoledehydroaripiprazole\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/ravimiseire-uuringud\\\/aripiprasool-ja-dehudroaripiprasool-p-aripiprasoledehydroaripiprazole\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"K\u00e4siraamat\",\"item\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Ravimiseire uuringud\",\"item\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/ravimiseire-uuringud\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Aripiprasool ja deh\u00fcdroaripiprasool (P-Aripiprasole+dehydroaripiprazole)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/#website\",\"url\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/\",\"name\":\"\u00dchendlabor\",\"description\":\"Hoolivus, Uuendusmeelsus, P\u00e4devus ja Usaldusv\u00e4\u00e4rsus\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"et\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aripiprasool ja deh\u00fcdroaripiprasool (P-Aripiprasole+dehydroaripiprazole) - \u00dchendlabor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/ravimiseire-uuringud\/aripiprasool-ja-dehudroaripiprasool-p-aripiprasoledehydroaripiprazole\/","og_locale":"et_EE","og_type":"article","og_title":"Aripiprasool ja deh\u00fcdroaripiprasool (P-Aripiprasole+dehydroaripiprazole) - \u00dchendlabor","og_description":"Kliinilise keemia ja laboratoorse hematoloogia osakond Aripiprasool kuulub at\u00fc\u00fcpiliste e teise p\u00f5lvkonna antips\u00fchhootiliste ravimite r\u00fchma, mida kasutatakse skisofreenia ja I t\u00fc\u00fcpi bipolaarse meeleoluh\u00e4ire ravis t\u00e4iskasvanutel ning lastel. Aripiprasooli manustatakse suukaudselt ning see imendub h\u00e4sti, saavutades maksimaalse plasmakontsentratsiooni 3\u20135 tunni jooksul peale manustamist. Veres transporditakse aripiprasooli peamiselt albumiiniga seotult. Ravimi metabolism toimub maksas, kus tekib ka [&hellip;]","og_url":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/ravimiseire-uuringud\/aripiprasool-ja-dehudroaripiprasool-p-aripiprasoledehydroaripiprazole\/","og_site_name":"\u00dchendlabor","article_modified_time":"2025-12-11T15:12:58+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutit"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/ravimiseire-uuringud\/aripiprasool-ja-dehudroaripiprasool-p-aripiprasoledehydroaripiprazole\/","url":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/ravimiseire-uuringud\/aripiprasool-ja-dehudroaripiprasool-p-aripiprasoledehydroaripiprazole\/","name":"Aripiprasool ja deh\u00fcdroaripiprasool (P-Aripiprasole+dehydroaripiprazole) - \u00dchendlabor","isPartOf":{"@id":"https:\/\/www.kliinikum.ee\/yhendlabor\/#website"},"datePublished":"2025-07-30T15:48:32+00:00","dateModified":"2025-12-11T15:12:58+00:00","breadcrumb":{"@id":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/ravimiseire-uuringud\/aripiprasool-ja-dehudroaripiprasool-p-aripiprasoledehydroaripiprazole\/#breadcrumb"},"inLanguage":"et","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/ravimiseire-uuringud\/aripiprasool-ja-dehudroaripiprasool-p-aripiprasoledehydroaripiprazole\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/ravimiseire-uuringud\/aripiprasool-ja-dehudroaripiprasool-p-aripiprasoledehydroaripiprazole\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.kliinikum.ee\/yhendlabor\/"},{"@type":"ListItem","position":2,"name":"K\u00e4siraamat","item":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/"},{"@type":"ListItem","position":3,"name":"Ravimiseire uuringud","item":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/ravimiseire-uuringud\/"},{"@type":"ListItem","position":4,"name":"Aripiprasool ja deh\u00fcdroaripiprasool (P-Aripiprasole+dehydroaripiprazole)"}]},{"@type":"WebSite","@id":"https:\/\/www.kliinikum.ee\/yhendlabor\/#website","url":"https:\/\/www.kliinikum.ee\/yhendlabor\/","name":"\u00dchendlabor","description":"Hoolivus, Uuendusmeelsus, P\u00e4devus ja Usaldusv\u00e4\u00e4rsus","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.kliinikum.ee\/yhendlabor\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"et"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false},"uagb_author_info":{"display_name":"Kadi Siigur","author_link":"https:\/\/www.kliinikum.ee\/yhendlabor\/author\/kadisi\/"},"uagb_comment_info":0,"uagb_excerpt":"Kliinilise keemia ja laboratoorse hematoloogia osakond Aripiprasool kuulub at\u00fc\u00fcpiliste e teise p\u00f5lvkonna antips\u00fchhootiliste ravimite r\u00fchma, mida kasutatakse skisofreenia ja I t\u00fc\u00fcpi bipolaarse meeleoluh\u00e4ire ravis t\u00e4iskasvanutel ning lastel. Aripiprasooli manustatakse suukaudselt ning see imendub h\u00e4sti, saavutades maksimaalse plasmakontsentratsiooni 3\u20135 tunni jooksul peale manustamist. Veres transporditakse aripiprasooli peamiselt albumiiniga seotult. Ravimi metabolism toimub maksas, kus tekib ka&hellip;","_links":{"self":[{"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/pages\/12452","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/comments?post=12452"}],"version-history":[{"count":0,"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/pages\/12452\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/pages\/7301"}],"wp:attachment":[{"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/media?parent=12452"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}